Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.84 USD | -9.31% | -2.28% | -29.86% |
May. 08 | Olema Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 02 | Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 550M |
---|---|---|---|---|---|
Net income 2024 * | -135M | Net income 2025 * | -166M | EV / Sales 2024 * | - |
Net cash position 2024 * | 82.2M | Net cash position 2025 * | 129M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.11
x | P/E ratio 2025 * |
-3.75
x | Employees | 74 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.89% |
Latest transcript on Olema Pharmaceuticals, Inc.
1 day | -9.31% | ||
1 week | -2.28% | ||
Current month | -3.24% | ||
1 month | -14.66% | ||
3 months | -36.88% | ||
6 months | -39.07% | ||
Current year | -29.86% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Kushner
FOU | Founder | 86 | 06-08-06 |
Sean Bohen
CEO | Chief Executive Officer | 58 | 20-08-31 |
Cyrus Harmon
FOU | Founder | 54 | 06-08-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Clark
CHM | Chairman | 62 | 20-07-31 |
J. Garland
BRD | Director/Board Member | 55 | 23-10-15 |
Andy Rappaport
BRD | Director/Board Member | 66 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.59% | 4 M€ | -5.15% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 0 M€ | +3.48% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 9.84 | -9.31% | 1,170,868 |
24-05-08 | 10.85 | -3.47% | 611,232 |
24-05-07 | 11.24 | +3.12% | 670,592 |
24-05-06 | 10.9 | +2.16% | 380,104 |
24-05-03 | 10.67 | +5.96% | 697,741 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.86% | 550M | |
+23.37% | 47.02B | |
+49.90% | 41.86B | |
-0.94% | 41.76B | |
-4.27% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
+30.23% | 12.34B | |
-2.67% | 11.82B |
- Stock Market
- Equities
- OLMA Stock